1
TÍTULO: Safety, Resource Use, and Quality of Life in PARAMOUNT A Phase III Study of Maintenance Pemetrexed Versus Placebo after Induction Pemetrexed Plus Cisplatin for Advanced Nonsquamous Non-Small-Cell Lung Cancer
AUTORES: Cesare Gridelli; Filippo de Marinis; Jean Louis Pujol; Martin Reck; Rodryg Ramlau; Barbara Parente; Thierry Pieters; Gary Middleton; Jesus Corral; Katherine Winfree; Symantha Melemed; Anna Zimmermann; William John; Julie Beyrer; Nadia Chouaki; Carla Visseren Grul; Luis G Paz Ares;
PUBLICAÇÃO: 2012, FONTE: JOURNAL OF THORACIC ONCOLOGY, VOLUME: 7, NÚMERO: 11
INDEXADO EM: Scopus WOS
2
TÍTULO: Second-line therapy for non-small cell lung cancer in clinical practice: final results and treatment pathways from the SELECTTION observational study
AUTORES: Alain Vergnenegre; Egbert F Smit; Elisabeth Toy; Barbara Parente; Stephan Schmitz; Kees Kraaij; Victoria Soldatenkova; Carla Visseren Grul; Giovanni Zanotti; Kaisa Taipale; Denis Moro Sibilot;
PUBLICAÇÃO: 2012, FONTE: CURRENT MEDICAL RESEARCH AND OPINION, VOLUME: 28, NÚMERO: 8
INDEXADO EM: Scopus WOS CrossRef
3
TÍTULO: Second-line therapy for NSCLC in clinical practice: baseline results of the European SELECTTION observational study
AUTORES: Denis Moro Sibilot; Alain Vergnenegre; Egbert F Smit; Elisabeth Toy; Barbara Parente; Stephan Schmitz; Kees Kraaij; Carla Visseren Grul; Victoria Soldatenkova; Jorge Arellano; Claudia Leteneux;
PUBLICAÇÃO: 2010, FONTE: CURRENT MEDICAL RESEARCH AND OPINION, VOLUME: 26, NÚMERO: 11
INDEXADO EM: Scopus WOS
5
TÍTULO: Observation of survival and its prognostic factors in patients undergoing chemotherapy for advanced non-small cell lung cancer (NSCLC). A3-02
AUTORES: Nicholas Thatcher; Heather Anderson; Helge G Bischoff; Ben van den Borne; Frank Langer; Ciara Moneley; Francisco Pimentel; Henrik Riska; Michael Thomas; Carla Visseren Grul;
PUBLICAÇÃO: 2007, FONTE: JOURNAL OF THORACIC ONCOLOGY, VOLUME: 2, NÚMERO: 8
INDEXADO EM: WOS CrossRef